secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOROX CO /DE/ (CLX)
CIK:        0000021076
Form:       8-K
Filed at:   2022-08-03T23:59:59+00:00
Accession:  0000021076-22-000021
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clorox Q4 net sales flat, gross margin compressed; announces streamlined operating model; FY23 cautious
--------------------------------------------------------------------------------

- Q4 net sales flat at $1.8B; organic sales +1%; diluted EPS $0.81 (+4% YoY); adjusted EPS $0.93 (-2%).
- FY22 net sales $7.1B (-3% YoY); gross margin 35.8% vs 43.6% prior year; free cash flow $535M vs $945M.
- Health & Wellness segment volume -18% in Q4; net sales -5% despite pricing benefits; three-year avg growth +3%.
- Announces streamlined operating model to create faster, simpler company, move decision-making closer to consumers.
- FY23 outlook: environment remains difficult with inflation and portfolio normalization; expects margin rebuilding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/21076/000002107622000021/0000021076-22-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/21076/000002107622000021/clx-20220803.htm
  HTML page:      https://secwatch.observer/filing/0000021076-22-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer